C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 4.01 USD Market Closed
Market Cap: 283.1m USD
Have any thoughts about
C4 Therapeutics Inc?
Write Note

Wall Street
Price Targets

CCCC Price Targets Summary
C4 Therapeutics Inc

Wall Street analysts forecast CCCC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CCCC is 16.47 USD with a low forecast of 8.08 USD and a high forecast of 40.95 USD.

Lowest
Price Target
8.08 USD
101% Upside
Average
Price Target
16.47 USD
311% Upside
Highest
Price Target
40.95 USD
921% Upside

CCCC Last Price Targets
C4 Therapeutics Inc

The latest public price target was made on Sep 19, 2024 by Etzer Darout from BMO Capital , who expects CCCC stock to rise by 399% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Etzer Darout
BMO Capital
20 USD
Upside 399%
2 months ago
Sep 19, 2024
BMO Capital Reiterates Outperform Rating on C4 Therapeutics (CCCC)
StreetInsider
Etzer Darout
BMO Capital
Price Target 20 USD
Upside/Downside 399%
View Source
C4 Therapeutics Inc Competitors:
Price Targets
145020
Hugel Inc
40% Upside
HPHA
Heidelberg Pharma AG
431% Upside
ALRN
Aileron Therapeutics Inc
414% Upside
MDGL
Madrigal Pharmaceuticals Inc
9% Upside
CRVO
Diffusion Pharmaceuticals Inc
513% Upside
4587
PeptiDream Inc
25% Upside
MCRB
Seres Therapeutics Inc
441% Upside
ARMP
Armata Pharmaceuticals Inc
217% Upside

Revenue
Forecast

Revenue Estimate
C4 Therapeutics Inc

For the last 4 years the compound annual growth rate for C4 Therapeutics Inc's revenue is -1%. The projected CAGR for the next 3 years is -5%.

-1%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
C4 Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
C4 Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CCCC's stock price target?
Price Target
16.47 USD

According to Wall Street analysts, the average 1-year price target for CCCC is 16.47 USD with a low forecast of 8.08 USD and a high forecast of 40.95 USD.

What is C4 Therapeutics Inc's Revenue forecast?
Projected CAGR
-5%

For the last 4 years the compound annual growth rate for C4 Therapeutics Inc's revenue is -1%. The projected CAGR for the next 3 years is -5%.

Back to Top